CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a polymer-based system for the safe delivery of a human growth factor to enhance bone regeneration. The technology aims to improve clinical outcomes in treating bone defects while reducing complications associated with high doses.
We propose a robust polymer-based system that allows a safer delivery of recombinant human bone morphogenetic protein-2 (rhBMP2) for bone tissue engineering.
We have teamed up with a surgeon (Dr.
Meek) and an SME (Taragenyx Ltd.) in the planning stages, for the appraisal of the proposal from a translational standpoint.
Later, Taragenyx will also be involved with scaling-up and commercialisation.
We filed a patent covering the technology, and licensed Taragenyx its exploitation. rhBMP2 is a power…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
